1 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow nirsevimab: new trials by email Literature Review of nirsevimab trials Research Report on nirsevimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants SIBP-A16 injection, Nirsevimab, SIBP-A16 buffer solution - Respiratory Syncytial Virus (RSV) | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Institute Of Biological Products | 36 | 2026-01-15 | 2026-01-23 |
| Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults nirsevimab, Placebo - Evaluate PK Profile | Phase 1 | Completed | AstraZeneca | 24 | 2021-06-22 | 2023-11-02 |
Premature Birth (1)
AstraZeneca (1) · Shanghai Institute Of Biological Products (1)
China (2)
Hanwen Liu (1)